Could HIV drugs slow Alzheimer's? new safety trial begins
NCT ID NCT07210528
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This study tests whether two HIV medications, emtricitabine and Descovy, are safe for people with mild cognitive impairment (MCI), a condition that can lead to Alzheimer's. Researchers think these drugs might slow disease progression by blocking a process linked to Alzheimer's. About 48 participants will take either the drug or a placebo daily for 3 months, with safety and early effects on memory and inflammation being monitored.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DEMENTIA (AD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National University Hospital
Singapore, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new PET tracer light up Alzheimer's plaques in the living brain?
- Could Brain-Boosting exercises help older adults stay steady on their feet?
- Brain scans could unlock the hidden timeline of Alzheimer's
- Could breathing hydrogen protect the aging brain?
- App aims to empower older adults with memory challenges to master medication routines
- Could simple exercises slow cognitive decline? a new trial investigates.